Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Multicenter Study to Compare the Immunological Efficacy and Safety of GC3110B With GCFLU Quadrivalent Inj. Administered Intramuscularly in Healthy Adults

NCT02915809 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT02915809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02915809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Multicenter Study to Compare the Immunological Efficacy and Safety of GC3110B With GCFLU Quadrivalent Inj. Administered Intramuscularly in Healthy Adults
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2016
Completion date
May 31, 2017
Enrollment
414 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, human